When we compared NrCAM mRNA levels in cerebral cortex, midbrain and hippocampal samples from individuals who were heterozygotes for this 5’ NrCAM haplotype to samples from individuals who lacked it, expression was about 40% lower in the brains of individuals who displayed the disease-associated haplotype. None of the adjacent genes’ expression revealed such evidence for haplotype-specific differential expression.